Yale University Executive and Leadership Team

Matt Lyles, the President at Yale University, directs the overarching strategic vision for the institution's research infrastructure, including the PET Core facility. Lyles architects the financial and operational frameworks that allow the center to function as a revenue-neutral, fee-for-service provider. By overseeing the allocation of resources for the GE PETtrace cyclotron and radiochemistry labs, the President ensures that the facility remains at the forefront of molecular imaging. This leadership role involves balancing the needs of 21 departments while maintaining the high standards required for NIH-funded research. Matt Lyles drives the expansion of clinical research support, enabling the facility to serve diverse patient populations across the region. Through the coordination of long-term institutional goals, the President supports the integration of preclinical studies into the broader academic mission. Lyles secures the financial stability of the imaging center by fostering inter-institutional partnerships and optimizing the utilization of advanced research equipment.

Hamilton Wan, the President at Yale University, manages the high-level governance and policy framework for the Yale Biomedical Imaging Institute. Wan architects the collaborative environment necessary for the PET Core to provide seamless service to researchers across New England. By focusing on the scalability of radiopharmaceutical development, the President ensures that the facility meets the growing demand for molecular imaging. This leadership role involves evaluating the impact of research outcomes on the university's broader scientific contributions. Hamilton Wan drives the adoption of new technologies within the radiochemistry lab, maintaining the facility's competitive edge in radiosynthesis validation. Through the oversight of institutional priorities, the President aligns the PET Core's operations with the university's commitment to innovation. Wan secures the operational continuity of the center by managing complex stakeholder relationships and ensuring that all imaging services remain compliant with federal research standards and institutional guidelines.

Afnan Shure, the President at Yale University, directs the strategic initiatives related to the facility's role in supporting NIH-funded research. Shure architects the operational roadmap for the eight research-dedicated PET scanners, ensuring maximum uptime and research throughput. By prioritizing the development of new radiotracers, the President enhances the facility's capacity for groundbreaking molecular imaging. This leadership role involves coordinating with the Yale Biomedical Imaging Institute to ensure that preclinical studies are conducted with the highest level of scientific rigor. Afnan Shure drives the integration of metabolite analysis services into the broader clinical research portfolio. Through the management of institutional resources, the President supports the diverse needs of researchers across 21 departments. Shure secures the facility's position as a vital resource for the regional scientific community by fostering a culture of continuous improvement and technical excellence in all radiopharmaceutical manufacturing and imaging activities.

Joshua Baize, the Associate Director, Communications & President, Office of at Yale University, manages the internal and external messaging for the PET Core facility. Baize architects the communication strategy that highlights the facility's expertise in radiopharmaceutical development and molecular imaging. By overseeing the flow of information between the Yale Biomedical Imaging Institute and the 21 departments served, the Associate Director, Communications & President, Office of ensures that researchers remain informed about available services. This leadership role involves coordinating with the President's office to align communication efforts with the university's strategic research goals. Joshua Baize drives the promotion of the facility's capabilities in pharmacokinetic studies and radiosynthesis validation. Through the management of digital and print outreach, the Associate Director, Communications & President, Office of supports the facility's mission to provide comprehensive clinical research support. Baize secures the visibility of the center's contributions to NIH-funded research across the New England region.

Antonio Cilibrizzi, the President of the Italian Undergraduate Society at Yale University, directs student-led initiatives that intersect with the university's broader research and academic community. Cilibrizzi architects programs that foster engagement between undergraduate students and the advanced research facilities housed under the Yale Biomedical Imaging Institute. By facilitating connections between the student body and the PET Core, the President of the Italian Undergraduate Society ensures that the next generation of researchers gains exposure to molecular imaging and radiopharmaceutical manufacturing. This leadership role involves organizing seminars and collaborative events that highlight the facility's role in NIH-funded research. Antonio Cilibrizzi drives awareness of the center's capabilities in preclinical studies and clinical research support. Through the management of society activities, the President of the Italian Undergraduate Society supports the university's mission of academic excellence. Cilibrizzi secures the integration of student perspectives into the broader institutional dialogue regarding scientific innovation and research infrastructure.

Andrew Alam-Nist, the Founder & President at Yale University, directs the development of specialized research initiatives that utilize the PET Core's imaging capabilities. Alam-Nist architects the framework for new collaborative projects that leverage the GE PETtrace cyclotron for innovative radiopharmaceutical research. By focusing on the intersection of technology and clinical application, the Founder & President ensures that the facility remains a leader in molecular imaging. This leadership role involves identifying emerging research trends and aligning the facility's resources to support these areas. Andrew Alam-Nist drives the expansion of the center's service offerings, including advanced metabolite analysis and radiosynthesis validation. Through the management of strategic partnerships, the Founder & President supports the university's commitment to NIH-funded research. Alam-Nist secures the long-term viability of the facility by fostering an environment of innovation and ensuring that the center's services meet the evolving needs of researchers across the 21 departments served.

Michael Maldonado, the Co President at Yale University, manages the operational oversight of the PET Core facility in conjunction with other leadership members. Maldonado architects the logistical processes required to maintain the facility's status as a revenue-neutral, fee-for-service provider. By focusing on the efficiency of the radiochemistry lab, the Co President ensures that all radiosynthesis validation and imaging services are delivered on time and within budget. This leadership role involves coordinating with the Yale Biomedical Imaging Institute to optimize the use of the eight research-dedicated PET scanners. Michael Maldonado drives the implementation of quality control measures that support the facility's FDA-registered status. Through the management of daily operations, the Co President supports the diverse clinical research needs of patient populations throughout New England. Maldonado secures the operational success of the center by ensuring that all technical and administrative functions are aligned with the university's high standards for research excellence.

Kevin Billingsley, the Chief Medical Officer at Yale University, directs clinical safety protocols and regulatory compliance for the PET Core facility. Billingsley oversees the integration of FDA-registered radiotracer manufacturing into broader clinical research workflows. By managing the intersection of molecular imaging and patient care, the Chief Medical Officer ensures that all human studies meet rigorous safety standards. This leadership role involves coordinating with the Yale Biomedical Imaging Institute to align medical research objectives with institutional capabilities. Kevin Billingsley maintains oversight of pharmacokinetic studies and metabolite analysis, ensuring data integrity across all 21 departments. Through the supervision of clinical research support, the Chief Medical Officer drives the facility's mission to provide high-quality imaging services. Billingsley secures the operational success of the center by bridging the gap between complex radiochemistry and practical clinical application for diverse patient populations throughout New England.

John Marcucci, the Chief People Officer at Yale University, manages the human capital strategy for the specialized staff operating the GE PETtrace cyclotron and radiochemistry laboratories. Marcucci architects talent acquisition and professional development programs tailored to the highly technical requirements of molecular imaging research. By fostering a culture of precision and safety, the Chief People Officer ensures that the facility retains top-tier expertise for complex radiosynthesis validation. This leadership role involves aligning departmental staffing needs with the revenue-neutral, fee-for-service model of the Yale Biomedical Imaging Institute. John Marcucci drives organizational efficiency by optimizing team structures across the 21 departments served by the center. Through the implementation of performance metrics and training initiatives, the Chief People Officer supports the long-term sustainability of the research workforce. Marcucci maintains a focus on operational excellence, ensuring that the personnel supporting NIH-funded research remain equipped to handle advanced preclinical and human imaging studies.

E.J. Crawford, the Chief Communications Officer at Yale University, manages the dissemination of research findings and institutional messaging regarding the PET Core facility. Crawford architects the strategic outreach to clinicians and researchers across New England to maximize the utilization of the eight research-dedicated PET scanners. By translating complex radiopharmaceutical developments into accessible narratives, the Chief Communications Officer enhances the visibility of the Yale Biomedical Imaging Institute. This leadership role involves coordinating with internal stakeholders to promote the facility's capabilities in metabolite analysis and pharmacokinetic studies. E.J. Crawford drives engagement with the broader scientific community, ensuring that the value of the center's FDA-registered manufacturing services remains clear. Through the management of institutional branding and research reporting, the Chief Communications Officer supports the growth of NIH-funded projects. Crawford secures the reputation of the facility as a premier inter-institutional service provider by maintaining consistent and transparent communication channels.